📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Aptorum

1.1 - Company Overview

Aptorum Logo

Aptorum

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, with a focus on infectious diseases and cancers, including orphan oncology indications.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Aptorum

AN2 Therapeutics Logo

AN2 Therapeutics

HQ: United States Website
  • Description: Provider of boron chemistry–based drug discovery and clinical development for infectious diseases, including epetraborole, an oral therapy in development for chronic non-tuberculous mycobacterial lung disease targeting Mycobacterium avium complex, and conducting clinical trials to obtain regulatory approval for new medications for infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AN2 Therapeutics company profile →
OM Pharma Logo

OM Pharma

HQ: Switzerland Website
  • Description: Provider of microbial-derived immunotherapeutic products addressing acute and chronic immunological disorders from infections and inflammation, operating worldwide through partners and investing in R&D. Products include Broncho-Vaxom to regulate the immune system and prevent recurrent respiratory infections, Uro-Vaxom to treat and prevent recurrent lower urinary tract infections, and Dicynone for capillary hemorrhage prevention and treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OM Pharma company profile →
Alphyn Biologics Logo

Alphyn Biologics

HQ: United States Website
  • Description: Provider of proprietary drug therapies for skin diseases, including Zabalafin hydrogel (AB-101a), a steroid-free topical for atopic dermatitis targeting immune and bacterial components; the Zabalafin (AB-101) multi-bioactive platform; and AB-101b in development for Epidermolysis Bullosa to address inflammation, itch, pain, and skin infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alphyn Biologics company profile →
Binx Health Logo

Binx Health

HQ: United States Website
  • Description: Provider of point-of-care and at-home diagnostic solutions, including binx io for chlamydia and gonorrhea testing with results in about thirty minutes; at-home STI sample collection kits available via digital health platforms; and at-home COVID-19 nasal swab sample collection kits for individual and bulk orders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Binx Health company profile →
Oxsed Logo

Oxsed

HQ: United Kingdom Website
  • Description: Provider of accurate and rapid testing worldwide to minimize the impact of disease on individuals and communities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxsed company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Aptorum

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Aptorum

2.2 - Growth funds investing in similar companies to Aptorum

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Aptorum

4.2 - Public trading comparable groups for Aptorum

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Aptorum

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Aptorum

What does Aptorum do?

Aptorum is a provider of pharmaceutical discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, with a focus on infectious diseases and cancers, including orphan oncology indications.

Who are Aptorum's competitors?

Aptorum's competitors and similar companies include AN2 Therapeutics, OM Pharma, Alphyn Biologics, Binx Health, and Oxsed.

Where is Aptorum headquartered?

Aptorum is headquartered in United Kingdom.

How many employees does Aptorum have?

Aptorum has 1,000 employees 🔒.

When was Aptorum founded?

Aptorum was founded in 2010 🔒.

What sector and industry vertical is Aptorum in?

Aptorum is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Aptorum

Who are the top strategic acquirers in Aptorum's sector and industry

Top strategic M&A buyers and acquirers in Aptorum's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Aptorum?

Top strategic M&A buyers groups and sectors for Aptorum include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Aptorum's sector and industry vertical

Which are the top PE firms investing in Aptorum's sector and industry vertical?

Top PE firms investing in Aptorum's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Aptorum's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Aptorum's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Aptorum's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Aptorum include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Aptorum's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Aptorum?

The key public trading comparables and valuation benchmarks for Aptorum include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Aptorum for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Aptorum with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Aptorum's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Aptorum with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Aptorum's' sector and industry vertical?

Access recent funding rounds and capital raises in Aptorum's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Aptorum